Our Latest News

[NEWS] – Biofortis obtains ANSM authorization and strengthens its position in the development of microbiota-derived therapies

Biofortis announces that it has obtained authorization from the French National Agency for the Safety of Medicines and Health Products (ANSM) for its activities involving the collection of human stool samples intended for the preparation of fecal microbiota for...
[NEWS] ACCELERATE YOUR ASSAYS

[NEWS] ACCELERATE YOUR ASSAYS

In a continuous improvement of our performance and analytical capabilities that's complements Biofortis Central lab,...

Explore

our success stories

Contact

our team

Discover

our capabilities